ribociclib
novartis
['kisqali', 'breast']
kisqali may help reduce risk of most common breast cancer subtype from returning, says new data from lead author dr. dennis slamon . see what else experts from &amp; had to say about this exciting study. #asco23 
The trusted source for information on cancer built in collaboration with millions of patients and the country's leading academic medical centers.